Correspondence (reply): In Reply

di Dührsen, Ulrich
Pubblicato in Dtsch Arztebl Int (2020)

Evidence-Based Follow-up for Adults With Cancer

di Dührsen, Ulrich, Deppermann, Karl-Matthias, Pox, Christian, Holstege, Axel
Pubblicato in Dtsch Arztebl Int (2019)

Growth factor independence 1 (Gfi1) regulates cell-fate decision of a bipotential granulocytic-monocytic precursor defined by expression of Gfi1 and CD48

di Vassen, Lothar, Dührsen, Ulrich, Kosan, Christian, Zeng, Hui, Möröy, Tarik
Pubblicazione 2012

Cytopenia first – hepatitis second: an unusual sequence in aplastic anemia

di Alashkar, Ferras, Föhring, Daniel, Dührsen, Ulrich, Baba, Hideo Andreas, Röth, Alexander
Pubblicato in Clin Case Rep (2017)

Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability

di Broecker-Preuss, Martina, Becher-Boveleth, Nina, Bockisch, Andreas, Dührsen, Ulrich, Müller, Stefan
Pubblicato in J Transl Med (2017)

Telomere loss, senescence, and genetic instability in CD4(+) T lymphocytes overexpressing hTERT

di Röth, Alexander, Baerlocher, Gabriela M., Schertzer, Mike, Chavez, Elizabeth, Dührsen, Ulrich, Lansdorp, Peter M.
Pubblicazione 2005

CpG stimulation of chronic lymphocytic leukemia cells induces a polarized cell shape and promotes migration in vitro and in vivo

di Dampmann, Maria, Görgens, André, Möllmann, Michael, Murke, Florian, Dührsen, Ulrich, Giebel, Bernd, Dürig, Jan
Pubblicato in PLoS One (2020)

Phase I/II trial of lenalidomide, methotrexate, leucovorin, cytarabine, and rituximab (LeMLAR) in relapsed or refractory diffuse large B cell lymphoma

di Dührsen, Ulrich, Tometten, Mareike, Kroschinsky, Frank, Ganser, Arnold, Ibach, Stefan, Bertram, Stefanie, Hüttmann, Andreas
Pubblicato in Blood Cancer J (2021)

No evidence for hypogammaglobulinemia in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with ravulizumab

di Alashkar, Ferras, Rottinghaus, Scott, Vance, Colin, Herich-Terhürne, Dörte, Dührsen, Ulrich, Assert, Roland, Röth, Alexander
Pubblicato in PLoS One (2020)

Inflammation-driven activation of JAK/STAT signaling reversibly accelerates acute myeloid leukemia in vitro

di Habbel, Jan, Arnold, Lucas, Chen, Yiyang, Möllmann, Michael, Bruderek, Kirsten, Brandau, Sven, Dührsen, Ulrich, Hanoun, Maher
Pubblicato in Blood Adv (2020)

Gfi1 and Gfi1b act equivalently in haematopoiesis, but have distinct, non-overlapping functions in inner ear development

di Fiolka, Katharina, Hertzano, Ronna, Vassen, Lothar, Zeng, Hui, Hermesh, Orit, Avraham, Karen B, Dührsen, Ulrich, Möröy, Tarik
Pubblicazione 2006

Long-term outcome of hemizygous and heterozygous carriers of a germline GATA1(G208R) mutation

di Dührsen, Ulrich, Kratz, Christian P., Flotho, Christian, Lauenstein, Thomas, Bommer, Martin, König, Erika, Brittinger, Günter, Heimpel, Hermann
Pubblicazione 2010

Fertility preservation and fulfillment of parenthood after treatment of hematological malignancies: results from the ‘Aftercare in Blood Cancer Survivors’ (ABC) study

di Schmitz, Christine, Baum, Julia, Lax, Hildegard, Lehmann, Nils, Gromke, Tanja, Beelen, Dietrich W., Jöckel, K.-H., Dührsen, Ulrich
Pubblicato in Int J Clin Oncol (2020)

Pregnancy in Classical Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia–Paroxysmal Nocturnal Hemoglobinuria: A High-Risk Constellation

di Alashkar, Ferras, Saner, Fuat H., Vance, Colin, Schmücker, Ute, Herich-Terhürne, Dörte, Dührsen, Ulrich, Köninger, Angela, Röth, Alexander
Pubblicato in Front Med (Lausanne) (2020)

Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial

di Röth, Alexander, Bommer, Martin, Hüttmann, Andreas, Herich-Terhürne, Dörte, Kuklik, Nils, Rekowski, Jan, Lenz, Veronika, Schrezenmeier, Hubert, Dührsen, Ulrich
Pubblicato in Blood Adv (2018)

The Role of Whole-Body Magnetic Resonance Imaging (WB-MRI) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

di Alashkar, Ferras, Schemuth, Haemi Phaedra, Nensa, Felix, Göbel, Juliane, Vance, Colin, Forsting, Michael, Dührsen, Ulrich, Schlosser, Thomas Wilfried, Röth, Alexander
Pubblicato in Sci Rep (2018)

Supporting data for positron emission tomography-based risk modelling using a fixed-instead of a relative thresholding method for total metabolic tumor volume determination

di Schmitz, Christine, Hüttmann, Andreas, Müller, Stefan P., Hanoun, Maher, Boellaard, Ronald, Brinkmann, Marcus, Jöckel, Karl-Heinz, Dührsen, Ulrich, Rekowski, Jan
Pubblicato in Data Brief (2019)

Genetic Variants of the NKG2C/HLA-E Receptor–Ligand Axis Are Determinants of Progression-Free Survival and Therapy Outcome in Aggressive B-Cell Lymphoma

di Wagner, Bettina, Dührsen, Ulrich, Hüttmann, Andreas, Nückel, Holger, Michita, Rafael Tomoya, Rohn, Hana, Schramm, Sabine, Horn, Peter A., Rebmann, Vera
Pubblicato in Cancers (Basel) (2020)

Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche

di Hanoun, Maher, Zhang, Dachuan, Mizoguchi, Toshihide, Pinho, Sandra, Pierce, Halley, Kunisaki, Yuya, Lacombe, Julie, Armstrong, Scott A., Dührsen, Ulrich, Frenette, Paul S.
Pubblicazione 2014

Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas

di Johansson, Patricia, Klein-Hitpass, Ludger, Grabellus, Florian, Arnold, Georg, Klapper, Wolfram, Pförtner, Roman, Dührsen, Ulrich, Eckstein, Anja, Dürig, Jan, Küppers, Ralf
Pubblicato in Oncotarget (2016)